Cargando…
Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease
BACKGROUND: Novel cardiac magnetic resonance (CMR) stress T1 mapping can detect ischemia and myocardial blood volume changes without contrast agents and may be a more comprehensive ischemia biomarker than myocardial blood flow. OBJECTIVES: This study describes the performance of the first prospectiv...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Biomedical
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835225/ https://www.ncbi.nlm.nih.gov/pubmed/29495995 http://dx.doi.org/10.1016/j.jacc.2017.11.071 |
_version_ | 1783303774523097088 |
---|---|
author | Liu, Alexander Wijesurendra, Rohan S. Liu, Joanna M. Greiser, Andreas Jerosch-Herold, Michael Forfar, John C. Channon, Keith M. Piechnik, Stefan K. Neubauer, Stefan Kharbanda, Rajesh K. Ferreira, Vanessa M. |
author_facet | Liu, Alexander Wijesurendra, Rohan S. Liu, Joanna M. Greiser, Andreas Jerosch-Herold, Michael Forfar, John C. Channon, Keith M. Piechnik, Stefan K. Neubauer, Stefan Kharbanda, Rajesh K. Ferreira, Vanessa M. |
author_sort | Liu, Alexander |
collection | PubMed |
description | BACKGROUND: Novel cardiac magnetic resonance (CMR) stress T1 mapping can detect ischemia and myocardial blood volume changes without contrast agents and may be a more comprehensive ischemia biomarker than myocardial blood flow. OBJECTIVES: This study describes the performance of the first prospective validation of stress T1 mapping against invasive coronary measurements for detecting obstructive epicardial coronary artery disease (CAD), defined by fractional flow reserve (FFR <0.8), and coronary microvascular dysfunction, defined by FFR ≥0.8 and the index of microcirculatory resistance (IMR ≥25 U), compared with first-pass perfusion imaging. METHODS: Ninety subjects (60 patients with angina; 30 healthy control subjects) underwent CMR (1.5- and 3-T) to assess left ventricular function (cine), ischemia (adenosine stress/rest T1 mapping and perfusion), and infarction (late gadolinium enhancement). FFR and IMR were assessed ≤7 days post-CMR. Stress and rest images were analyzed blinded to other information. RESULTS: Normal myocardial T1 reactivity (ΔT1) was 6.2 ± 0.4% (1.5-T) and 6.2 ± 1.3% (3-T). Ischemic viable myocardium downstream of obstructive CAD showed near-abolished T1 reactivity (ΔT1 = 0.7 ± 0.7%). Myocardium downstream of nonobstructive coronary arteries with microvascular dysfunction showed less-blunted T1 reactivity (ΔT1 = 3.0 ± 0.9%). Stress T1 mapping significantly outperformed gadolinium-based first-pass perfusion, including absolute quantification of myocardial blood flow, for detecting obstructive CAD (area under the receiver-operating characteristic curve: 0.97 ± 0.02 vs. 0.91 ± 0.03, respectively; p < 0.001). A ΔT1 of 1.5% accurately detected obstructive CAD (sensitivity: 93%; specificity: 95%; p < 0.001), whereas a less-blunted ΔT1 of 4.0% accurately detected microvascular dysfunction (area under the receiver-operating characteristic curve: 0.95 ± 0.03; sensitivity: 94%; specificity: 94%: p < 0.001). CONCLUSIONS: CMR stress T1 mapping accurately detected and differentiated between obstructive epicardial CAD and microvascular dysfunction, without contrast agents or radiation. |
format | Online Article Text |
id | pubmed-5835225 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier Biomedical |
record_format | MEDLINE/PubMed |
spelling | pubmed-58352252018-03-07 Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease Liu, Alexander Wijesurendra, Rohan S. Liu, Joanna M. Greiser, Andreas Jerosch-Herold, Michael Forfar, John C. Channon, Keith M. Piechnik, Stefan K. Neubauer, Stefan Kharbanda, Rajesh K. Ferreira, Vanessa M. J Am Coll Cardiol Article BACKGROUND: Novel cardiac magnetic resonance (CMR) stress T1 mapping can detect ischemia and myocardial blood volume changes without contrast agents and may be a more comprehensive ischemia biomarker than myocardial blood flow. OBJECTIVES: This study describes the performance of the first prospective validation of stress T1 mapping against invasive coronary measurements for detecting obstructive epicardial coronary artery disease (CAD), defined by fractional flow reserve (FFR <0.8), and coronary microvascular dysfunction, defined by FFR ≥0.8 and the index of microcirculatory resistance (IMR ≥25 U), compared with first-pass perfusion imaging. METHODS: Ninety subjects (60 patients with angina; 30 healthy control subjects) underwent CMR (1.5- and 3-T) to assess left ventricular function (cine), ischemia (adenosine stress/rest T1 mapping and perfusion), and infarction (late gadolinium enhancement). FFR and IMR were assessed ≤7 days post-CMR. Stress and rest images were analyzed blinded to other information. RESULTS: Normal myocardial T1 reactivity (ΔT1) was 6.2 ± 0.4% (1.5-T) and 6.2 ± 1.3% (3-T). Ischemic viable myocardium downstream of obstructive CAD showed near-abolished T1 reactivity (ΔT1 = 0.7 ± 0.7%). Myocardium downstream of nonobstructive coronary arteries with microvascular dysfunction showed less-blunted T1 reactivity (ΔT1 = 3.0 ± 0.9%). Stress T1 mapping significantly outperformed gadolinium-based first-pass perfusion, including absolute quantification of myocardial blood flow, for detecting obstructive CAD (area under the receiver-operating characteristic curve: 0.97 ± 0.02 vs. 0.91 ± 0.03, respectively; p < 0.001). A ΔT1 of 1.5% accurately detected obstructive CAD (sensitivity: 93%; specificity: 95%; p < 0.001), whereas a less-blunted ΔT1 of 4.0% accurately detected microvascular dysfunction (area under the receiver-operating characteristic curve: 0.95 ± 0.03; sensitivity: 94%; specificity: 94%: p < 0.001). CONCLUSIONS: CMR stress T1 mapping accurately detected and differentiated between obstructive epicardial CAD and microvascular dysfunction, without contrast agents or radiation. Elsevier Biomedical 2018-03-06 /pmc/articles/PMC5835225/ /pubmed/29495995 http://dx.doi.org/10.1016/j.jacc.2017.11.071 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Alexander Wijesurendra, Rohan S. Liu, Joanna M. Greiser, Andreas Jerosch-Herold, Michael Forfar, John C. Channon, Keith M. Piechnik, Stefan K. Neubauer, Stefan Kharbanda, Rajesh K. Ferreira, Vanessa M. Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease |
title | Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease |
title_full | Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease |
title_fullStr | Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease |
title_full_unstemmed | Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease |
title_short | Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease |
title_sort | gadolinium-free cardiac mr stress t1-mapping to distinguish epicardial from microvascular coronary disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835225/ https://www.ncbi.nlm.nih.gov/pubmed/29495995 http://dx.doi.org/10.1016/j.jacc.2017.11.071 |
work_keys_str_mv | AT liualexander gadoliniumfreecardiacmrstresst1mappingtodistinguishepicardialfrommicrovascularcoronarydisease AT wijesurendrarohans gadoliniumfreecardiacmrstresst1mappingtodistinguishepicardialfrommicrovascularcoronarydisease AT liujoannam gadoliniumfreecardiacmrstresst1mappingtodistinguishepicardialfrommicrovascularcoronarydisease AT greiserandreas gadoliniumfreecardiacmrstresst1mappingtodistinguishepicardialfrommicrovascularcoronarydisease AT jeroschheroldmichael gadoliniumfreecardiacmrstresst1mappingtodistinguishepicardialfrommicrovascularcoronarydisease AT forfarjohnc gadoliniumfreecardiacmrstresst1mappingtodistinguishepicardialfrommicrovascularcoronarydisease AT channonkeithm gadoliniumfreecardiacmrstresst1mappingtodistinguishepicardialfrommicrovascularcoronarydisease AT piechnikstefank gadoliniumfreecardiacmrstresst1mappingtodistinguishepicardialfrommicrovascularcoronarydisease AT neubauerstefan gadoliniumfreecardiacmrstresst1mappingtodistinguishepicardialfrommicrovascularcoronarydisease AT kharbandarajeshk gadoliniumfreecardiacmrstresst1mappingtodistinguishepicardialfrommicrovascularcoronarydisease AT ferreiravanessam gadoliniumfreecardiacmrstresst1mappingtodistinguishepicardialfrommicrovascularcoronarydisease |